NEW YORK (GenomeWeb) – Pressure Biosciences today reported its revenues from products and services increased 14 percent year over year for the third quarter ended Sept. 30, as its overall revenues slipped 11 percent.

Total revenues, generated wholly from the sale of products and services, were $372,545, down 11 percent from $420,762 in Q3 2013. Products and services revenue in Q3 2013 was $327,958. Consumables sales were $52,000, nearly flat with $51,000 for Q3 2013.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.